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CASE REPORT
A case of fever following antiepileptic treatment
S. Gatzonis, A. Laiaki, A. Chioni, A. Siafakas, CH. Zournas & V. Mantouvalos
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University, Athens, Greece
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A 23-year-old female patient treated with 900 mg oxcarbazepine for complex partial seizures is presented. Good seizure control
and slight fever were noted a few weeks after drug administration. Reduction of oxcarbazepine and replacement with valproate
resulted in a transient normothermia. Because of fever reappearance, vigabatrin was added and valproate was gradually reduced.
Seizures reappeared, but the body temperature fell below 37 C. Substitution of valproate for lamotrigine resulted in seizure
control but abnormal body temperature (37–37:6 C) was noted again. Repeated hospital admission for clinical and laboratory
investigation before any change of treatment revealed no other abnormal findings. The patient’s abnormal temperature possibly
reflects a derangement of high-level temperature control.
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During treatment with antiepileptic drugs mild or se-
vere side-effects are not unusual1. Many of them are
well known and have been classified. The appearance
of a side-effect always poses the question of discontin-
uation of the responsible drug. The problem becomes
more complicated when an extremely rare or unknown
side-effect is present or when the patient takes more
than one antiepileptic drug.
We present a 23-year-old female epileptic patient
who developed a slight elevation of body tempera-
ture without other accompanying symptoms following
treatment with oxcarbazepine, valproate and lamotrig-
ine.
Case report
A 20-year-old female suffering from complex partial
seizures since the age of 12 was admitted 3 years ago to
our hospital. She had never received any antiepileptic
treatment before.
A clinical and laboratory investigation was normal.
Oxacarbazepine 300 mg  2 daily for 2 weeks was
administered; following that 300 mg  3 daily. Rou-1059–1311/99/030187 + 03 $12.00/0tine biochemical and haematological screens that were
done on the 5th, 26th and 46th days were normal. The
patient complained of dysmenorrhoea and menstrual
delay in the first months of the treatment. In addition,
she reported a slight elevation of body temperature. She
measured her body temperature almost every day for
contraceptive reasons. Although her body temperature
was 36.5–36:8 C in the previous years, after treatment
it reached over 37 C. Measuring body temperature six
times per day for 3 months confirmed these findings,
and the patient was hospitalized and investigated for
fever of unknown aetiology. The investigation did not
reveal any abnormal findings.
A gradual reduction of oxcarbazepine and substitu-
tion for 1500 mg valproate was suggested. Gradually
the temperature returned to pre-treatment levels; and
she now had three to four simple seizures per month.
Four months later she again noted temperatures over
37 C (from 37 C to 37:6 C). She was again hospital-
ized for a detailed investigation which did not reveal
any abnormal finding.
Valproate was reduced to 800 mg daily and vigabatrin
(1500 mg) was added. She was seizure-free, although
the body temperature was again abnormal. A further
reduction of valproate resulted in gradual seizure reap-
pearance.c© 1999 BEA Trading Ltd
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Fig. 1: Vertical axon, temperatures in Celsius grade; horizontal, measures (about 2.000) and months. Black cycle (), seizure;
wide lines at the bottom, duration of treatment of each antiepileptic drug; oxcarbazepine; valproate; vigabatrin; lamotrigine.
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nal of Medicine 1964; 36: 956–957.Lamotrigine was the next antiepilepic drug admin-
istered. Very good seizure control was achieved with
up to 150 mg of lamotrigine and 2000 mg of vigaba-
trin daily. Gradually vigabatrin was withdrawn and the
patient was almost seizure-free, but her temperature
remained over 37 C all this time. Thirty months later
there was still no change (Fig. 1).
Discussion
Our patient had measured her temperature at 36:2 C to
36:9 C but not over 37 C for 2 years before antiepilep-
tic treatment. The abnormal measurements were noted
3 months after antiepileptic treatment administration.
She did not complain of thermal discomfort or other
symptoms.
The fever clearly appeared after oxcarbazepine
administration, and lasted for almost 3 years in spite
of therapy with four different antiepileptic drugs. No
reports of fever as a side-effect after oxcarbazepine
administration have been cited. Fever as an idiosyn-
cratic side-effect has been reported for valproate or
lamotrigine2, 3.
As has already been mentioned, the first and second
extensive clinical and laboratory evaluations did not
yield abnormal findings. A slow progressive subclin-
ical illness is rather unlikely, as 30 months after the
second hospitalization no other significant symptoms
have been seen.
Because of the negative results of extended clinical
and laboratory investigation and the absence of accom-
panying symptoms such as asthenia, fatigue or thermal
discomfort, we now consider that our patient did not
have ‘fever’ but a derangement of the ‘set-point’ around
which body temperature is regulated.
There are heat and cold sensitive neurons in the brain
which are capable of driving physiological and behav-
ioral thermoregulatory responses in a way to keep a
constant ‘set-point’ for body temperature.
There is some evidence for the influence of oxcar-
bazepine on the hypothalamus. Oxcarbazepine can pro-
duce hyponatremia, presumably by either increasing
output of antidiuretic hormone or by influencing os-
moreceptors4.
The influence of antiepileptic drugs on ion concen-
tration is a possible underlying mechanism, as there are
data which suggest that the physiological basis for the
‘set-point’ of temperature control is the inherent ratio
of sodium to calcium ions in the posterior hypothala-mus5. The drugs administered to the patient alter Na
conductance.
It is also possible that AEDs may act on central ac-
tion peptides with antipyretic properties or on central
neurotransmitters influencing thermoregulation6.
Wolf et al. (1964) reported periodic hyperthermia
lasting 3 to 5 days and recurring once a week7. The
basis for this disorder was not certain, but diencephalic
epilepsy was considered a possibility. In our patient
the steadiness of abnormal temperature eliminates the
possibility of existence of an epileptic mechanism in
central control areas responsible for the abnormal tem-
perature. Moreover, abnormal temperature occurred in
periods where seizure control was good.
Idiosyncratic cross-reaction to oxcarbazepine, val-
proate and lamotrigine seems to be extremely rare. In
conclusion, no specific mechanism can be definitely
identified for this persistent rise in temperature.
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